Who owns Denali Therapeutics Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of DNLI from SEC Form 13F filings across 294 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 294 institutions disclosed 156.2M shares of Denali Therapeutics Inc. worth $4.46B — about 83.4% of shares outstanding; the largest disclosed holder is T. Rowe Price Investment Management, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
294
13F holders
$4.46B
value, 2026 filers
83.4%
of shares outstanding (156.2M sh)
58
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of DNLI's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | T. Rowe Price Investment Management, Inc. | 16.2M | $416.1M | 0.3% | 8.6% | +89.9% |
| 2 | BlackRock, Inc. | 14.0M | $360.8M | 0.0% | 7.5% | +7.6% |
| 3 | BAILLIE GIFFORD & CO | 12.0M | $307.6M | 0.3% | 6.4% | -0.9% |
| 4 | STATE STREET CORP | 7.0M | $181.3M | 0.0% | 3.8% | +12.4% |
| 5 | Temasek Holdings (Private) Ltd | 7.0M | $180.4M | 0.5% | 3.7% | 0.0% |
| 6 | VANGUARD PORTFOLIO MANAGEMENT LLC | 6.5M | $166.6M | 0.0% | 3.5% | +5.8% |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 6.3M | $161.4M | 0.0% | 3.4% | +2.1% |
| 8 | FMR LLC | 4.5M | $116.7M | 0.0% | 2.4% | -0.9% |
| 9 | GOLDMAN SACHS GROUP INC | 4.2M | $106.9M | 0.0% | 2.2% | -5.7% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 4.0M | $102.2M | 0.0% | 2.1% | +6.6% |
| 11 | Holocene Advisors, LP | 3.9M | $100.4M | 0.2% | 2.1% | +22.2% |
| 12 | BAKER BROS. ADVISORS LP | 3.7M | $96.0M | 0.5% | 2% | +0.1% |
| 13 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 3.2M | $81.3M | 0.0% | 1.7% | -28.7% |
| 14 | PRICE T ROWE ASSOCIATES INC /MD/ | 3.1M | $80.7M | 0.0% | 1.7% | +27.3% |
| 15 | UBS Group AG | 3.1M | $80.3M | 0.0% | 1.7% | +21.4% |
| 16 | ALLIANCEBERNSTEIN L.P. | 3.0M | $57.3M | 0.0% | 1.6% | +3.2% |
| 17 | DIMENSIONAL FUND ADVISORS LP | 2.9M | $73.6M | 0.0% | 1.5% | +6.3% |
| 18 | NORGES BANKNEW | 2.8M | $72.7M | 0.0% | 1.5% | new |
| 19 | Pictet Asset Management Holding SA | 2.8M | $71.9M | 0.1% | 1.5% | +9.1% |
| 20 | Capital Research Global Investors | 2.6M | $66.0M | 0.0% | 1.4% | +2.0% |
| 21 | Fisher Asset Management, LLC | 2.4M | $62.1M | 0.0% | 1.3% | -0.9% |
| 22 | NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 2.2M | $56.8M | 0.1% | 1.2% | +1828.2% |
| 23 | Casdin Capital, LLC | 2.0M | $52.6M | 2.6% | 1.1% | +11.1% |
| 24 | Crestline Management, L.P. | 1.9M | $49.1M | 91.9% | 1% | -13.6% |
| 25 | PRINCIPAL FINANCIAL GROUP INC | 1.4M | $36.5M | 0.0% | 0.8% | -4.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.